FDA will have two new acting associate commissioners as it implements the next round of user fee legislation and prepares for potentially massive budgetary belt tightening.
After 17 years at FDA and on Capitol Hill, David Dorsey is jumping to Janssen Research & Development LLC to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?